Holding(s) In Company
Bank of America Corporation has notified Faron Pharmaceuticals Oy of a change in its major holdings, crossing a threshold on June 12, 2026, due to an acquisition or disposal of financial instruments. The resulting situation shows Bank of America Corporation holding 0.12% of shares and voting rights directly, and 9.99% through financial instruments, totaling 10.11% of the issuer's 206,411,888 shares and voting rights. This represents a decrease from its previous notification, where it held 0.13% directly and 10.07% through financial instruments, for a total of 10.20%.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | June 17, 2026 at 09:00:00 EEST |
Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FIN-FSA)
- Identity of the issuer: FARON PHARMACEUTICALS OY
- Details of person subject to the notification obligation:
| Name: Bank of America Corporation | City and country of residence: Wilmington, DE, United States of America |
- Full name of shareholder(s) (if different from 3.): -
- Date on which the threshold was crossed or reached: 12.6.2026
- Total positions of person(s) subject to the notification obligation:
| Resulting situation on the date on which threshold was crossed or reached | 0.12 | 9.99 | 10.11 | 206,411,888 | |
| Position of previous notification (if applicable) | 0.13 | 10.07 | 10.20 | ||
| A: Shares and voting rights | |||||
| Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | ||
| FI4000153309 | 0 | 246,335 | 0 | 0.12 | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| SUBTOTAL A | 246,335 | 0.12 | |||
| B: Financial Instruments according to SMA 9:6a | |||||
| Rights of Use | n/a | n/a | n/a | 20,374,993 | 9.87 |
| Swaps | 15/10/2027 | n/a | Cash | 245,294 | 0.12 |
| - | - | - | - | - | - |
| SUBTOTAL B | 20,620,287 | 9.99 | |||
| - | - | - | - | ||
| - | - | - | - | ||
| - | - | - | - | ||
| - | - | - | - | ||
| - | - | - | - | ||
- In case of proxy voting: [ name of the proxy holder ] will cease to hold [% and number ] voting rights as of Click here to enter a date.
- Additional information:
Done at London, United Kingdom on 15.6.2026.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.